SCHEMBL22871815

SCHEMBL22871815

CC1(C)c2ccccc2N(c2ccc3c(c2)C(C)(C)c2cc(-c4cc(-c5cccnc5)nc(-c5cccnc5)c4)ccc2N3c2ccccc2)c2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.49
EGLN1 Q9GZT9 1/20 0.38
PDK2 Q15119 2/20 0.37
CYP2A6 P11509 1/20 0.36
CYP11B1 P15538 4/20 0.35
CYP11B2 P19099 4/20 0.35
CYP17A1 P05093 2/20 0.35
CYP1A2 P05177 3/20 0.35
USP8 P40818 1/20 0.35
MAPT P10636 2/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 1/20 0.35
BACE1 P56817 1/20 0.35
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
DHODH Q02127 1/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20230684 0.92 CYP19A1 (0.40) CYP19A1EGLN1PDK2CYP2A6CYP1A2
SCHEMBL21510469 0.92 CYP19A1 (0.48) CYP19A1EGLN1PDK2CYP2A6CYP11B1
SCHEMBL20230672 0.90 MEN1 (0.35) CYP19A1EGLN1CYP1A2MAPTALDH1A1
SCHEMBL20230739 0.88 CYP19A1 (0.44) CYP19A1EGLN1PDK2CYP2A6CYP11B1
SCHEMBL15084750 0.87 PDK2 (0.40) CYP19A1EGLN1PDK2CYP2A6CYP11B1
SCHEMBL15084800 0.87 KMT2A (0.38) CYP19A1EGLN1PDK2MAPTALDH1A1
SCHEMBL21973898 0.86 CYP19A1 (0.54) CYP19A1EGLN1PDK2CYP2A6CYP11B1
SCHEMBL20230698 0.85 CYP19A1 (0.44) CYP19A1EGLN1PDK2CYP11B1CYP11B2
SCHEMBL13833117 0.84 MEN1 (0.35) CYP19A1PDK2CYP1A2MAPTALDH1A1
SCHEMBL21510464 0.84 PDK2 (0.40) CYP19A1EGLN1PDK2CYP2A6CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10892423-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10892423-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNE2, CCNT1 CYP19A1 305/4885EGLN1 2396/4885PDK2 1964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.